The outcome of increased ROS levels—either promoting tumor proliferation or, conversely, tumor growth suppression and cell death induction—is related to the ability of mitochondria to release the apoptogenic factors, such as the pro-apoptotic members of the Bcl-2 family, or AIF and cytochrome C. The gene discussed is BCL2; the disease is neoplasm.